APA (7th ed.) Citation

B, S., D, R., A, W., WC, C., JM, P., J, Z., . . . J, N. (2025). Dual treatment with Val-083 and AZD1775 shows potent anti-tumor activity in diffuse midline glioma models. NPJ precision oncology, 9(1), 209. https://doi.org/10.1038/s41698-025-01006-4

Chicago Style (17th ed.) Citation

B, Subramaniam, et al. "Dual Treatment with Val-083 and AZD1775 Shows Potent Anti-tumor Activity in Diffuse Midline Glioma Models." NPJ Precision Oncology 9, no. 1 (2025): 209. https://doi.org/10.1038/s41698-025-01006-4.

MLA (9th ed.) Citation

B, Subramaniam, et al. "Dual Treatment with Val-083 and AZD1775 Shows Potent Anti-tumor Activity in Diffuse Midline Glioma Models." NPJ Precision Oncology, vol. 9, no. 1, 2025, p. 209, https://doi.org/10.1038/s41698-025-01006-4.